Learn more →
Back to Expert Scholars
surgical / surgicalsarcoma surgery

Alessandro Gronchi

亚历山德罗·格隆基

MD

🏢Fondazione IRCCS Istituto Nazionale dei Tumori, Milan(米兰国家肿瘤研究所)🌐Italy

Director, Department of Surgery; Head, Sarcoma Surgery Program外科部主任;肉瘤外科项目负责人

52
h-index
2
Key Papers
3
Awards
3
Key Contributions

👥Biography 个人简介

Alessandro Gronchi is the director of surgery at the Istituto Nazionale dei Tumori in Milan and the world's foremost authority on retroperitoneal sarcoma surgery. He founded and co-chairs the TransAtlantic Retroperitoneal Sarcoma Working Group (TARPSWG), which has produced landmark consensus guidelines and prospective data redefining surgical strategy for this challenging disease. His research has clarified the role of extended vs. standard resection for retroperitoneal liposarcoma and established the critical importance of histotype-tailored surgical approaches.

Share:

🧪Research Fields 研究领域

Retroperitoneal Sarcoma Surgery腹膜后肉瘤手术
Liposarcoma脂肪肉瘤
Leiomyosarcoma平滑肌肉瘤
Extremity Sarcoma Surgery四肢肉瘤手术
TARPSWG跨大西洋腹膜后肉瘤工作组

🎓Key Contributions 主要贡献

TARPSWG — Retroperitoneal Sarcoma Surgery Standards

Co-founded and led TARPSWG, a multinational collaboration producing the definitive consensus statement on surgical management of primary retroperitoneal sarcoma, establishing compartmental resection principles and histotype-specific surgical guidelines adopted internationally.

Extended vs. Standard Resection for Retroperitoneal Liposarcoma

Led the STRASS randomized phase III trial comparing extended resection with standard resection for primary retroperitoneal sarcoma, providing the only prospective randomized data in this disease and clarifying the marginal benefit of extended compartmental surgery specifically in dedifferentiated liposarcoma.

Histotype-Tailored Surgery and Nomogram Development

Developed and externally validated the Memorial Sloan Kettering/INT-Milan sarcoma nomograms predicting recurrence and survival after resection of retroperitoneal sarcoma, enabling individualized counseling and decision-making for patients and clinicians.

Representative Works 代表性著作

[1]

Preoperative Radiotherapy plus Surgery versus Surgery Alone for Patients with Primary Retroperitoneal Sarcoma (STRASS): A Phase 3, Open-Label, Randomised Controlled Trial

The Lancet Oncology (2020)

STRASS phase III trial evaluating neoadjuvant radiotherapy in retroperitoneal sarcoma, showing histotype-specific effects.

[2]

Multidisciplinary Management of Primary Retroperitoneal Sarcoma: Consensus Guidelines from TARPSWG

Annals of Surgical Oncology (2018)

International consensus guidelines for retroperitoneal sarcoma surgical management from the TARPSWG collaboration.

🏆Awards & Recognition 奖项与荣誉

🏆CTOS Distinguished Achievement in Surgery Award 2021
🏆Italian National Academy of Surgery Award 2018
🏆Society of Surgical Oncology James Ewing Lectureship 2023

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 亚历山德罗·格隆基 的研究动态

Follow Alessandro Gronchi's research updates

留下邮箱,当我们发布与 Alessandro Gronchi(Fondazione IRCCS Istituto Nazionale dei Tumori, Milan)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment